Moviprep Orange

Polyethylene glycol 3350 with electrolytes and ascorbic acid, the active ingredient in Moviprep Orange, is an osmotic laxative presented as a powder for oral solution for oral use. It is used to cleanse the bowel before colonoscopy or sigmoidoscopy procedures.

GNH USA supplies Moviprep Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU manufacturers to ensure quality and regulatory compliance. Our distribution network reaches major healthcare facilities across Europe, Asia, Africa and the Americas.

Moviprep Orange, an osmotic laxative used for bowel preparation, is indicated for the following clinical situations: - Colonoscopy: effective bowel cleansing to enable clear visualization during colonoscopy. - Sigmoidoscopy: bowel cleansing to facilitate sigmoidoscopic examination. - Pre‑procedural bowel preparation: preparation of the colon before other diagnostic or therapeutic procedures requiring a clean bowel.

Moviprep Orange may cause a range of adverse reactions, most of which are related to its osmotic activity and electrolyte composition.

Common Side Effects: - Nausea: mild to moderate nausea during or after ingestion. - Abdominal cramping: intermittent cramping or discomfort. - Diarrhea: watery stools as the bowel is cleared. - Bloating: sensation of abdominal fullness or gas.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss leading to low blood pressure. - Electrolyte imbalance: abnormal potassium or sodium levels. - Allergic reaction: rash, itching, swelling, or anaphylaxis (rare).

Before prescribing Moviprep Orange, consider the following precautions to ensure safe and effective bowel preparation. - Renal impairment: assess kidney function and monitor electrolytes closely. - Cardiac disease: use caution in patients with heart failure or arrhythmias due to fluid shifts. - Gastrointestinal obstruction: contraindicated in known or suspected bowel obstruction. - Pregnancy and lactation: evaluate risk‑benefit; limited data available. - Concomitant laxatives: avoid using other osmotic agents simultaneously. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Moviprep Orange can interact with certain medicines; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Sodium‑containing medications: may exacerbate hypernatremia. - Loop diuretics: increase risk of electrolyte disturbances, especially hypokalemia. - Anticholinergic agents: may reduce efficacy of bowel cleansing.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor blood pressure and electrolytes. - Iron supplements: may affect absorption of the preparation. - Antacids containing magnesium or aluminum: could alter electrolyte balance.